Skip to main content
COR
NYSE Trade & Services

Cencora Posts $2.71 Q4 EPS as Drug Distributor Closes Fiscal Year

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Healthcare
Sentiment info
Positive
Importance info
7
Price
$343.67
Mkt Cap
$64.977B
52W Low
$244.82
52W High
$377.54
52W Position info
40% above low
Off High info
9.0% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

COR sits 40% above its 52-week low of $244.82.

Summary

Cencora reported fourth-quarter EPS of $2.71, with adjusted EPS of $4.66 versus an IBES estimate of USD 4.58, on revenue of $88.35B and net income of $519.4M. The company guided FY27 adjusted EPS to $19.40-$19.75 and set FY27 revenue growth of 3%-5%, and raised its quarterly dividend to 66c from 60c, a 10% increase. It also introduced new reportable segments — Pharmaceutical Distribution and Services, Specialty Pharmaceutical and Provider Services, and Other — effective fiscal 2027. Context matters here: the company raised FY26 EPS guidance twice this year, in May and again in August, and pulled forward a $1 billion buyback, so expectations into this print were elevated. The bigger overhang is the Walgreens volume that began moving outside the prime vendor agreement on July 1, disclosed in an August 8-K — this is the first quarterly report to fully reflect that headwind.

Updated with an SEC 8-K filing · What changed

Updates

  1. · SEC 8-K — Cencora introduced new reportable segments (Pharmaceutical Distribution and Services, Specialty Pharmaceutical and Provider Services, Other) effective fiscal 2027 and set FY27 revenue growth of 3%-5%.

At the time of this announcement, COR was trading at $343.67 on NYSE in the Trade & Services sector, with a market capitalization of approximately $65B. The 52-week trading range was $244.82 to $377.54. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

COR - Latest Insights

COR
Nov 13, 2026, 11:43 AM EST
Source: Reuters
Importance Score:
8
Price at Filing: $356.14
Real-time Price: $339.83 info
Change: -$16.31 (-5%) info
Market Cap: $64.931B info
COR
Nov 04, 2026, 9:25 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $345.75
Real-time Price: $339.83 info
Change: -$5.92 (-2%) info
Market Cap: $64.931B info
COR
Nov 04, 2026, 6:37 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $342.67
Real-time Price: $339.83 info
Change: -$2.84 (-0.83%) info
Market Cap: $64.931B info
COR
Oct 21, 2026, 7:48 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $342.51
Real-time Price: $339.83 info
Change: -$2.68 (-0.78%) info
Market Cap: $64.931B info
COR
Oct 21, 2026, 7:30 AM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $342.51
Real-time Price: $339.83 info
Change: -$2.68 (-0.78%) info
Market Cap: $64.931B info